 |
|
Long-Term Outcome of Amyotrophic Lateral Sclerosis in Korean Subjects
Mi Ri Suh, Won Ah Choi, Young-Chul Choi, Jang Woo Lee, Jung Hwa Hong, Jihyun Park, Seong-Woong Kang
Ann Rehabil Med. 2017;41(6):1055-1064. Published online 2017 Dec 28 DOI: https://doi.org/10.5535/arm.2017.41.6.1055
|
|
Citations to this article as recorded by
 A factâfinding survey of medical care provided to neuromuscular disease patients at the National Center of Neurology and Psychiatry in Japan
Akiko Hanai, Keisuke Yorimoto, Ryo Ohkubo, Tadashi Tsukamoto, Katsuhiro Mizuno, Yuji Takahashi
Neurology and Clinical Neuroscience.2023; 11(1): 32. CrossRef Interleukin 6 (IL6) level is a biomarker for functional disease progression within IL6R358Ala variant groups in amyotrophic lateral sclerosis patients
Marlena Wosiski-Kuhn, James B. Caress, Michael S. Cartwright, Gregory A. Hawkins, Carol Milligan
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.2021; 22(3-4): 248. CrossRef What is the Adequate Cuff Volume for Tracheostomy Tube? A Pilot Cadaver Study
Dong Min Kim, Myung Jun Shin, Sung Dong Kim, Yong Beom Shin, Ho Eun Park, Young Mo Kim, Jin A Yoon
Annals of Rehabilitation Medicine.2020; 44(5): 402. CrossRef
|